Alexander Schacht
Werner Reimers Str. 2-4
Bad Homburg Vor Der Hoehe, HE 61350, Germany
Bad Homburg Vor Der Hoehe, HE 61350, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
Minimizing Urban Carbon Emissions and Heat Island Intensity: A theoretical study.
Journal: PloS one
Published: October 22, 2024
Parahydrogen-Induced Polarization of a Labeled, Cancer-Targeting DNA Aptamer.
Journal: Angewandte Chemie (International ed. in English)
Published: January 11, 2023
Leading beyond regulatory approval: Opportunities for statisticians to optimize evidence generation and impact clinical practice.
Journal: Pharmaceutical statistics
Published: August 19, 2022
Multilevel network meta-regression for population-adjusted treatment comparisons.
Journal: Journal of the Royal Statistical Society. Series A, (Statistics in Society)
Published: July 21, 2020
Modeling Heterogeneity in Patients' Preferences for Psoriasis Treatments in a Multicountry Study: A Comparison Between Random-Parameters Logit and Latent Class Approaches.
Journal: PharmacoEconomics
Published: March 05, 2020
A 24-week multicentre, randomized, open-label, parallel-group study comparing the efficacy and safety of ixekizumab vs. fumaric acid esters and methotrexate in patients with moderate-to-severe plaque psoriasis naive to systemic treatment.
Journal: The British journal of dermatology
Published: July 30, 2019
What matters most? Different stakeholder perspectives on estimands for an invented case study in COPD.
Journal: Pharmaceutical statistics
Published: March 18, 2019
Combination of several matching adjusted indirect comparisons (MAICs) with an application in psoriasis.
Journal: Pharmaceutical statistics
Published: March 02, 2018
Matching-adjusted indirect comparison of efficacy in patients with moderate-to-severe plaque psoriasis treated with ixekizumab vs. secukinumab.
Journal: The British journal of dermatology
Published: November 14, 2017
Cost per additional responder for ixekizumab and other FDA-approved biologics in moderate-to-severe plaque psoriasis.
Journal: Journal of medical economics
Published: August 02, 2017
Comment on "Quantitative Evaluation of Biologic Therapy Options for Psoriasis: A Systematic Review and Network Meta-Analysis".
Journal: The Journal of investigative dermatology
Published: June 05, 2017
A statistical method to convert published response rates into marginal distributions with an example application in psoriasis.
Journal: Pharmaceutical statistics
Published: November 22, 2016
Last Updated: 09/26/2026